Neogen (NEOG) Competitors

Neogen (NASDAQ:NEOG) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

Which has preferable earnings & valuation, NEOG or MMSI?

Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$913.83M	2.38	-$9.42M	-$2.19	-4.58
Merit Medical Systems	$1.26B	4.78	$94.41M	$2.04	50.57

Does the media refer more to NEOG or MMSI?

In the previous week, Neogen had 13 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for Neogen and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.49 beat Neogen's score of -0.20 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Merit Medical Systems	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer NEOG or MMSI?

Neogen currently has a consensus target price of $14.00, suggesting a potential upside of 39.44%. Merit Medical Systems has a consensus target price of $109.80, suggesting a potential upside of 6.44%. Given Neogen's higher probable upside, equities research analysts clearly believe Neogen is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Merit Medical Systems	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00

Does the MarketBeat Community believe in NEOG or MMSI?

Merit Medical Systems received 111 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 69.72% of users gave Merit Medical Systems an outperform vote while only 56.58% of users gave Neogen an outperform vote.

Company	Underperform	Outperform
Neogen	Outperform Votes 331 56.58%	Underperform Votes 254 43.42%
Merit Medical Systems	Outperform Votes 442 69.72%	Underperform Votes 192 30.28%

Is NEOG or MMSI more profitable?

Merit Medical Systems has a net margin of 9.05% compared to Neogen's net margin of -52.12%. Merit Medical Systems' return on equity of 15.61% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-52.12%	2.89%	1.98%
Merit Medical Systems	9.05%	15.61%	8.38%

Do institutionals & insiders believe in NEOG or MMSI?

96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.1% of Neogen shares are owned by company insiders. Comparatively, 3.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more volatility & risk, NEOG or MMSI?

Neogen has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.

Summary

Merit Medical Systems beats Neogen on 16 of the 19 factors compared between the two stocks.